These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10540577)

  • 1. [Anticardiolipin antibodies in patients with Buerger's disease].
    Cnotliwy M; Gutowski P; Szumiłowicz H; Kucharska E; Jastrzebska M; Ostanek L
    Wiad Lek; 1999; 52(7-8):332-6. PubMed ID: 10540577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buerger's disease and anticardiolipin antibodies.
    Pereira de Godoy JM; Braile DM
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):792-4. PubMed ID: 19455050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thromboangiitis obliterans (Buerger's disease). Study of 41 cases].
    Fernández-Miranda C; Rubio R; Vicario JL; Arnaiz A; Fernández Sáez R; Mollejo M; Pulido F; del Palacio A; Lázaro T
    Med Clin (Barc); 1993 Sep; 101(9):321-6. PubMed ID: 8412397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A role of endothelin 1 in the pathogenesis of thromboangiitis obliterans (initital news)].
    Czarnacki M; Gacka M; Adamiec R
    Przegl Lek; 2004; 61(12):1346-50. PubMed ID: 15850327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex.
    Papa M; Bass A; Adar R; Halperin Z; Schneiderman J; Becker CG; Brautbar H; Mozes E
    Surgery; 1992 May; 111(5):527-31. PubMed ID: 1598672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aspects of thrombophilia in Buerger's disease].
    Caramaschi P; Biasi D; Volpe A; Carletto A; Bambara LM
    Recenti Prog Med; 2000 Sep; 91(9):436-40. PubMed ID: 11021165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two female nonsmoker Buerger's disease cases with anticardiolipin autoantibodies and a poor prognosis.
    Heper G; Kose S; Akkoc O; Amasyali B; Kilic A
    Int Heart J; 2005 May; 46(3):563-9. PubMed ID: 16043952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are anticardiolipin antibodies really important in thromboangiitis obliterans (Buerger's disease)?
    Olin JW
    Vasc Med; 2002; 7(4):257-8. PubMed ID: 12710839
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of thromboangiitis obliterans (Buerger's disease) with high-potency vasodilators.
    Jiménez-Gallo D; Albarrán-Planelles C; Arjona-Aguilera C; Blanco-Sánchez G; Rodríguez-Mateos ME; Linares-Barrios M
    Dermatol Ther; 2015; 28(3):135-9. PubMed ID: 25649782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Population genetics, immunologic evaluation and Buerger's disease. Projection through a personal study comprising 127 cases of juvenile arteriopathy].
    Schmitt J; Schmidt C; Alan C; Haller C; Perrier P
    Bull Acad Natl Med; 1993 Oct; 177(7):1153-62; discussion 1162-4. PubMed ID: 8149255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autonomic functions in Buerger's disease.
    Singh K; Sood S
    Indian J Physiol Pharmacol; 2001 Oct; 45(4):470-4. PubMed ID: 11883155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiendothelial cell antibodies in thromboangiitis obliterans.
    Eichhorn J; Sima D; Lindschau C; Turowski A; Schmidt H; Schneider W; Haller H; Luft FC
    Am J Med Sci; 1998 Jan; 315(1):17-23. PubMed ID: 9427570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buerger's disease and anticardiolipin antibodies: a worse prognosis?
    de Godoy JM; Braile DM; Godoy MF
    Clin Appl Thromb Hemost; 2002 Jan; 8(1):85-6. PubMed ID: 11991245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic image (195). A man with blue finger tips].
    de Vries PA; van Tol KM
    Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1290. PubMed ID: 15279212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-protein coupled receptor auto-antibodies in thromboangiitis obliterans (Buerger's disease) and their removal by immunoadsorption.
    Klein-Weigel PF; Bimmler M; Hempel P; Schöpp S; Dreusicke S; Valerius J; Bohlen A; Boehnlein JM; Bestler D; Funk S; Elitok S
    Vasa; 2014 Sep; 43(5):347-52. PubMed ID: 25147011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA in Buerger's disease.
    Numano F; Sasazuki T; Koyama T; Shimokado K; Takeda Y; Nishimura Y; Mutoh M
    Exp Clin Immunogenet; 1986; 3(4):195-200. PubMed ID: 3274054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One of the most frequent vascular diseases in northeastern of Turkey: Thromboangiitis obliterans or Buerger's disease (experience with 344 cases).
    Ates A; Yekeler I; Ceviz M; Erkut B; Pac M; Basoglu A; Kocak H
    Int J Cardiol; 2006 Jul; 111(1):147-53. PubMed ID: 16580754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Images in vascular medicine. Buerger's disease.
    Broz P; Jaeger KA
    Vasc Med; 2012 Oct; 17(5):366-7. PubMed ID: 22556152
    [No Abstract]   [Full Text] [Related]  

  • 19. Thromboangiitis obliterans (Buerger's disease).
    Klein-Weigel PF; Richter JG
    Vasa; 2014 Sep; 43(5):337-46. PubMed ID: 25147010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboangiitis obliterans with multiple large vessel involvement: case report and analysis of immunophenotypes.
    Edo N; Miyai K; Ogata S; Nakanishi K; Hiroi S; Tominaga S; Aiko S; Kawai T
    Cardiovasc Pathol; 2010; 19(1):59-62. PubMed ID: 19135391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.